Enumeration of Circulating Tumour Cells (CTCs) in Patients With Advanced Solid Malignancy Using Complementary Metal Oxide Semiconductor (CMOS) Technology

计划入组 31 人 · 首次发布于 2012 年 5 月 11 日

Extracranial-intracranial Bypass Surgery for Symptomatic Chronic Middle Cerebral Artery Occlusion: the CMOSS-2 Trial

计划入组 420 人 · 首次发布于 2023 年 6 月 12 日

CROS Application in CI

计划入组 9 人 · 首次发布于 2017 年 8 月 8 日

CMUS-100

Amos-1000

CMTS-0929

CMS Energy

United States

CMOL PHARMACEUTICALS AUSTRALIA PTY LTD

Australia

Axion BioSystems Acquires CytoTronics' High-Density CMOS MEA Technology to Advance Drug Discovery

China's NMPA Strengthens Contract Manufacturing Oversight, Sets New Quality Obligations for MAHs and CMOs

Sony, SCREEN, and VitroVo Launch High-Density MEA System Trial for Drug Discovery and Neurological Disease Research